The burden of new-onset diabetes mellitus after transplantation

Clinical Transplantation

Volumn 20, Issue 6, 2006, Pages 755-761

  Moore, Richard ^a   Ravindran, Vinod ^a   Baboolal, Kesh ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Diabetes mellitus; New onset; Post transplant; Risk; Transplantation

Indexed keywords

ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TSUKUBAENOLIDE;

ARTICLE; BEHAVIOR MODIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL STUDY; COST OF ILLNESS; DEATH; DIABETES MELLITUS; DIABETIC COMA; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG COST; FINANCIAL MANAGEMENT; GLYCEMIC CONTROL; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LIFESTYLE; LIVER TRANSPLANTATION; MORTALITY; PATIENT MONITORING; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; SURVIVAL RATE;

ABSTRACTING AND INDEXING; DIABETES MELLITUS; GRAFT SURVIVAL; HUMANS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL RATE;

EID: 33750843002     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00565.x     Document Type: Article

References (51)

1. Meier-Kriesche H-U, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutics strategies? Am J Transplant 2004: 4: 1289.
2. Howard RJ, Patton PR, Reed AI et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2003: 73: 1923.
3. Kavanagh D, Morris STW, Northridge DB, Rodger RS, Jardine AG. Electrocardiogram and outcome following renal transplantation. Nephron 1999: 81: 109.
4. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000: 57: 307.
5. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998: 339: 229.
6. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000: 11: 1735.
7. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995: 60: 451.
8. Kahn SE. The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003: 46: 3.
9. Ekstrand AV, Eriksson JG, Grönhagen-Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of post-transplantation diabetes in man. Transplantation 1992: 53: 563.
10. Hjelmesaeth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997: 64: 979.
11. Grinyo JM. Steroid sparing strategies in renal transplantation. Nephrol Dial Transplant 2005: 20: 2028.
12. Cho YM, Park KS, Jung HS et al. High incidence of tacrolimus-associated post-transplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care 2003: 26: 1123.
13. Nam JH, Mun JI, Kim SI et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001: 71: 1417.
14. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6 year study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 2003: 18: 2154.
15. Woodward RS, Schnitzler MA, Baty J et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003: 3: 590.
16. Kasiske B, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 178.
17. Friman S, Tuncer M, Wiecek A et.al. Evaluation of the incidence of glucose metabolism impairments after de novo kidney transplantation using an oral glucose tolerance test. Am J Transplant 2005: 5 (Suppl. 11): 408.
18. Cosio FG, Kudva Y, van der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005: 67: 2415.
19. Marchetti P. New-onset diabetes after liver transplantation: From pathogenesis to management. Liver Transpl 2005: 11: 612.
20. Eisen HJ, Irish WD, Schnitzler MA. Incidence of new onset diabetes mellitus (NODM) following orthotopic heart transplantation. Am J Transplant 2005: 5 (Suppl. 11): 407.
21. Davidson J, Wilkinson A, Dantal J et al., International Expert Panel. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003: 75: SS3.
22. Moore R, Boucher A, Carter J et.al Diabetes mellitus in transplantation: 2002 consensus guidelines. Transplant Proc 2003: 35: 1265.
23. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005: 19: 291.
24. Jindal RM, Hjelmesaeth J. Impact and management of posttransplant diabetes mellitus. Transplantation 2000: 70: S58.
25. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of Hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002: 13: 1374.
26. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004: 4: 583.
27. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 1998: 65: 515.
28. Baid S, Cosimi AB, Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001: 72: 1066.
29. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection. Liver Transplant 2004: 10: 349.
30. Levy G, Villamil F, Samuel D et al, LIS2T Study Group. Results of LIS2T, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation 2004: 77: 1632.
31. Schnitzler MA, Hardinger KA, Brennan DC. Low-dose tacrolimus and risk of new-onset diabetes following renal transplantation. Am J Transplant 2005: 5 (Suppl. 11): 548.
32. Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM. Development of diabetes mellitus following kidney transplantation: A Canadian experience. Am J Transplant 2004: 4: 1876.
33. Vincenti F, Friman S, Scheuermann E et.al. Glucose metabolism disorders after renal transplantation: Results of an international, randomized trial comparing cyclosporine versus tacrolimus. World Transplant Congress 2006: Abstract 50.
34. Montori VM, Velosa JA, Basu A, Gabriel SE, Erwin PJ, Kudva YC. Posttrasplantation diabetes: A systematic review of the literature. Diabetes Care 2002: 25: 583.
35. El-Atat F, Mc Farlane SI, Sowers JR. Diabetes, hypertension and cardiovascular derangements: Pathophysiology and management. Curr Hypertens Rep 2004: 6: 215.
36. Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: Current concepts. Am J Med 2004: 116 (Suppl. 5A): 11S.
37. Hjelmesaeth J, Hartmann A, Leivestad T et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006: 69: 588.
38. Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant associated diabetes? Transplantation 1998: 65: 380.
39. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001: 15: 89.
40. Friedman EA, Shyh TP, Beyer MM, Mans T, Butt KM. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985: 5: 196.
41. Torffvit O, Agardh CD. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. J Diabetes Complicat 2001: 15: 307.
42. Trail KC, Mc Cashland TM, Larsen JL et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996: 2: 276.
43. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002: 8: 708.
44. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002: 62: 1440.
45. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005: 16: 496.
46. Fellstrom B, Jardine AG, Soveri I et al, the ALERT Study Group. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant 2005: 5: 1986.
47. Boudreaux JP, Mc Hugh L, Canafax DM et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987: 44: 376.
48. Sumrani NB, Delaney V, Ding Z et al. Diabetes mellitus after renal transplantation in the cyclosporine era - an analysis of risk factors. Transplantation 1991: 51: 343.
49. Burroughs TE, Swindle J, Takemoto S et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2006 (in press).
50. Gordois A, Schuffham P, Shearer A, Oglesby A. The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complicat 2004: 18: 18.
51. Hollander AA, Hene RJ, Hermans J, van Es LA, van der Woude FJ. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: A randomized study. Nephrol Dial Transplant 2001: 16: 829.